Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

Completed · Phase 4

Conditions studied: Contact Lens, Contact Lens Discomfort, Contact Lens Dryness

In brief

The most common reason for contact lens discontinuation is contact lens discomfort. The investigators believe that inflammation plays a role in contact lens discomfort and the use of lifitegrast 5% ophthalmic solution may reduce end of the day contact lens discomfort. This study will enroll 21 contact lens users who will be receiving lifitegrast 5% ophthalmic solution and monitor the contact lens discomfort for a 8 week period while.

Key facts

Study ID

NCT03686878

Run by

EV Clinical Trials

People needed

21

Starts

2016-12-16

Expected to finish

2017-07-14

Last updated by the study team

2018-09-28

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Agree with study protocol
• Provide Informed Consent
• Age 21 or over
• Previous 10 months history of self-assessed comfortable wear samfilcon A contact lenses

You may not qualify if…

• Unable or unwilling to comply with study protocol
• Unable of unwilling to provide Informed consent
• Self-reported symptomatic intolerance of contact lenses
• History of an active anterior segment, eyelids, eyelashes, corneal or conjunctival pathology, ongoing ocular infection, inflammation or any other ocular problem that would require management with additional topical ophthalmic medications.
• Have had a history of corneal surgery (corneal transplants, LASIK, PRK).

Where it is running

• Eye & Vision — Richardson, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.